Dror Harats's guest appearances

Dror Harats

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Dr. Dror Harats, Founder and CEO of VBL Therapeutics, talks about the limitations of current treatments for recurrent glioblastoma multiforme (rGBM), the most common and deadliest form of brain cancer in adults and the challenges in developing new treatments to combat this devastating disease. The good news is that their lead candidate, a biologic agent called VB-111, is in late-stage clinical development for rGBM and showing great promise. He discusses the unique mechanism of VB-111 that he hopes could hold the key not only to treating rGBM, but many types of cancer. @VBL Therapeutic #GBM.  #Glioblastoma.  #BrainTumor   #BrainCancer.  #Cancer VBL Therapeutics VBLRX.com

Dr. Dror Harats, Founder and CEO of VBL Therapeutics, talks about the limitations of current treatments for recurrent glioblastoma multiforme (rGBM), the most common and deadliest form of brain cancer in adults and the challenges in developing new treatments to combat this devastating disease. The good news is that their lead candidate, a biologic agent called VB-111, is in late-stage clinical development for rGBM and showing great promise. He discusses the unique mechanism of VB-111 that he hopes could hold the key not only to treating rGBM, but many types of cancer. @VBL Therapeutic #GBM.  #Glioblastoma.  #BrainTumor   #BrainCancer.  #Cancer VBL Therapeutics <a href="http://vblrx.com" rel="nofollow" target="_blank">VBLRX.com</a>

Potential First in Class Gene Therapy for Glioblastoma GBM with Dr. Dror Harats VBL Therapeutics